Viewing Study NCT05099003


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-01-03 @ 2:01 AM
Study NCT ID: NCT05099003
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2021-11337
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators